EFFECTS OF ACTIVE SPECIFIC AND NON-SPECIFIC IMMUNOTHERAPY ON EMALEG2 LEUKAEMIA ACCORDING TO ROUTE OF ADMINISTRATION AND COMBINATION OF IMMUNOLOGICAL STIMULANTS

被引：12

作者：

AMIEL, JL

BERARDET, M

机构：

来源：

关键词：

D O I：

10.1016/0014-2964(71)90039-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：419 / &

共 9 条

[1] AMIEL JL, 1969, REV FR ETUD CLIN BIO, V14, P912
[2] AMIEL JL, 1969, REV FR ETUD CLIN BIO, V14, P685
[3] EXPERIMENTAL MODEL OF ACTIVE IMMUNOTHERAPY PRECEDED BY CYTOREDUCTIVE CHEMOTHERAPY
AMIEL, JL
BERARDET, M
[J]. EUROPEAN JOURNAL OF CANCER, 1970, 6 (06) : 557 - &
[4] AMIEL JL, 1967, REV FR ETUD CLIN BIO, V12, P912
[5] KAYIBANDA B, 1970, EUR J CLIN BIOL RES, V15, P437
[6] MATHE G, 1968, REV FR ETUD CLIN BIO, V13, P881
[7] ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKAEMIA
MATHE, G
AMIEL, JL
SCHWARZENBERG, L
SCHNEIDER, M
CATTAN, A
SCHLUMBERGER, JR
HAYAT, M
DEVASSAL, F
[J]. LANCET, 1969, 1 (7597) : 697 - +
[8] MATHE G, IN PRESS
[9] MOTTA R, 1970, EUR J CLIN BIOL RES, V15, P161